文献速递临床试验与 GCP基础与转化研究

早期宫颈癌微创与开腹根治性宫颈切除术的多中心随机对照试验方案

Minimally invasive versus open radical trachelectomy for early-stage cervical cancer: protocol for a multicenter randomized controlled trial in China.
PubMed 文献 · Trials · 2020-12-14

本研究为在中国28个中心开展的非劣效性随机对照试验,比较微创与开腹根治性宫颈切除术治疗早期宫颈癌的肿瘤学和生育结局。计划入组414例FIGO 2009分期IA1(伴脉管浸润)、IA2或IB1且肿瘤最大径≤2 cm、年龄18-40岁的患者,主要终点为无病生存期。

要点

  • 微创与开腹根治性宫颈切除术的肿瘤和生育结局对比证据有限。
  • 试验针对肿瘤≤2 cm、强烈要求保留生育功能的早期宫颈癌患者。
  • 主要终点为无病生存期,次要终点包括总生存、生育结局和生活质量。

核心结论

  • 该试验旨在为早期宫颈癌且强烈希望保留生育功能的患者提供微创与开腹手术选择的可靠证据。

研究设计与样本

  • 非劣效性随机对照试验,在中国28个中心开展,比较微创(机器人辅助或腹腔镜)与开腹根治性宫颈切除术。
  • 计划入组414例,按20%失访率计算,在0.050显著性水平下以90.1%把握度检测开腹组等效风险比0.75。

关键数值与推荐

  • 入组标准为FIGO 2009分期IA1(伴脉管浸润)、IA2或IB1宫颈癌,肿瘤最大径≤2 cm,组织学为鳞癌、腺癌或腺鳞癌,年龄18-40岁。
  • 主要终点为无病生存期,次要终点包括总生存率、无病生存率、生育结局和生活质量。

临床怎么用

  • 结果可为早期宫颈癌保留生育功能患者选择微创或开腹根治性宫颈切除术提供循证依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited data comparing the oncologic and fertility outcomes of patients with early-stage cervical cancer (CC) treated by minimally invasive radical trachelectomy (MIRT) or abdominal radical trachelectomy (ART). The purpose of this multicenter study is to compare the oncologic and fertility outcomes of patients treated by MIRT or ART in a randomized controlled manner in China. METHODS: This is a noninferiority, randomized controlled trial performed at 28 Chinese centers; the study is designed to compare the oncologic and fertility outcomes of patients treated by MIRT (robot-assisted or laparoscopic RT) or ART. Patients will be recruited if they have been diagnosed with stage IA1 (with lymphovascular space invasion), IA2, or IB1 CC (with a maximum tumor diameter ≤ 2 cm) in the FIGO 2009 staging system and histological subtypes of squamous carcinoma, adenocarcinoma, or adenosquamous carcinoma and if they are also aged 18 to 40 years. These candidates will be randomly assigned to undergo MIRT or ART. The primary endpoint will be disease-free survival. Secondary endpoints will consist of overall and disease-free survival rates, fertility outcomes, and quality of life. A total of 414 patients are needed to accomplish the study goal, with 90.1% power at a 0.050 significance level to detect an equivalence hazard ratio of 0.75 in the ART group, considering 20% loss to follow-up. DISCUSSION: The results of the trial should provide robust evidence to surgeons regarding options for the surgical approach in patients with early-stage CC who have a strong willingness to preserve fertility. TRIAL REGISTRATION: ClinicalTrials.gov NCT03739944 . Registered on November 14, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chao X, Li L, Wu M, et al. Minimally invasive versus open radical trachelectomy for early-stage cervical cancer: protocol for a multicenter randomized controlled trial in China. Trials. 2020. PMID: 33317612. doi:10.1186/s13063-020-04938-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。